Celmatix Inc. is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. With a lead “pipeline-in-a-pill” AMHR2 program focused on ovarian senescence, and collaborations in PCOS and non-hormonal contraception with industry leaders, Celmatix is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health.

Biotechnology

Celmatix

Celmatix's headquarters in New York, NY, United States

Piraye Yurttas Beim

Robert O'Connell

Charlotte Frank Sage

Adrienne Day

Craig Bolton

Stephen Palmer

Richard Anderson

Harald Dinter

Susan Herbert

Björn Hock

Joan-Carles Arce

Cory Ondrejka

David Sable

Linda C. Giudice

Roger Gosden

Mark Wolters

Kevin Lynch

Steve Winick

The Leadership Team at Celmatix is responsible for setting the strategic direction and vision of the company, guiding research and clinical development initiatives, and ensuring effective operational and financial management. Comprising experts in biological sciences, clinical research, and executive leadership, this team drives innovations in women’s health, oversees collaborations, and prioritizes the advancement of therapies targeting ovarian health challenges.

Leadership Team

The Scientific Advisory Team at Celmatix provides expert guidance on research and development strategies, ensuring the company's innovations align with the latest scientific advancements in ovarian biology. Comprised of leading experts in the field, the team advises on experimental design, data interpretation, and potential clinical applications to drive forward the company's mission of addressing unmet needs in women's health.

Scientific Advisory Team

Celmatix

Org chart

Board & advisors

Teams

Leadership Team

Scientific Advisory Team

Offices

Celmatix

Org chart

Board & advisors

Teams

Leadership Team

Scientific Advisory Team

Offices

Related companies